Call Traders Targeting Rallying Weight-Loss Drug Developer

Retrieved on: 2023-12-07 19:06:39

Tags for this article:

Click the tags to see associated articles and topics

Call Traders Targeting Rallying Weight-Loss Drug Developer. View article details on hiswai:

Excerpt

Options traders are targeting Altimmune Inc (NASDAQ:ALT), as the stock shoots for its 11th-straight win. CEO Vipin Garg told Reuters on Tuesday ...

Article found on: www.schaeffersresearch.com